Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper

Thureau, S.; Faivre, Jean; Assaker, Richard; Biver, Emmanuel; Confavreux, Cyrille; Debiais, Françoise; Duterque-Coquillaud, Martine; Giammarile, Francesco; Heymann, Dominique; Lecouvet, Frédéric; Morardet, Laëtitia; Paycha, Frédéric; Body, Jean‐Jacques; Vieillard, Marie-Hélène

doi:10.1016/j.jbo.2020.100291

Cited by 23 publications

(24 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In particular, lung cancer, hematopoietic stem cell transplantation, psychological aspects, and clinical research were discussed. Thureau et al, on behalf of the GEMO group (a European study group for bone metastases), discussed the topic of palliative RT for symptomatic bone metastases [ 36 ]. They indicated a single 8 Gy fraction as the recommended schedule for the palliation of bone pain.…”

Section: Resultsmentioning

confidence: 99%

“…We conducted a literature search using PubMed to identify articles published in English language that reported on cancer patient care recommendations during the COVID-19 pandemic from inception up to 1st June 2020, using the terms “(cancer or tumor) AND (COVID-19)” ( Table 1 ) [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , ...…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic

Zaniboni

Ghidini

Grossi

et al. 2020

Cancers

View full text Add to dashboard Cite

The COVID-19 pandemic has inevitably caused those involved in cancer care to change clinical practice in order to minimize the risk of infection while maintaining cancer treatment as a priority. General advice during the pandemic suggests that most patients continue with ongoing therapies or planned surgeries, while follow-up visits may instead be delayed until the resolution of the outbreak. We conducted a literature search using PubMed to identify articles published in English language that reported on care recommendations for cancer patients during the COVID-19 pandemic from its inception up to 1st June 2020, using the terms “(cancer or tumor) AND (COVID 19)”. Articles were selected for relevance and split into five categories: (1) personal recommendations of single or multiple authors, (2) recommendations of single authoritative centers, (3) recommendations of panels of experts or of multiple regional comprehensive centers, (4) recommendations of multicenter cooperative groups, (5) official guidelines or recommendations of health authorities. Of the 97 included studies, 10 were personal recommendations of single or multiple independent authors, 16 were practice recommendations of single authoritative cancer centers, 35 were recommendations provided by panel of experts or of multiple regional comprehensive centers, 19 were cooperative group position papers, and finally, 17 were official guidelines statements. The COVID-19 pandemic is a global emergency, and has rapidly modified our clinical practice. Delaying unnecessary treatment, minimizing toxicity, and identifying care priorities for surgery, radiotherapy, and systemic therapies must be viewed as basic priorities in the COVID-19 era.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic

Zaniboni

Ghidini

Grossi

et al. 2020

Cancers

View full text Add to dashboard Cite

show abstract

“…A single fractionated radiotherapy should be considered for cord compression or pain. [ 64 65 ] For other oncological emergencies, e.g., superior vena cava syndrome, raised intracranial tension due to brain metastasis, tumor bleeding should be considered for short courses of radiotherapy. [ 66 ] Patients who require frequent hospital visits for drainage of pleural or ascitic fluids, indwelling long term catheters, e.g., PleurX should be used.…”

Section: S Olutions For the N Eedsmentioning

confidence: 99%

Palliative care delivery in cancer patients in the era of Covid-19 outbreak: Unique needs, barriers, and tools for solutions

Mishra¹,

Biswas²,

Bhatnagar³

2020

Indian J Palliat Care

View full text Add to dashboard Cite

World is facing a pandemic recently due to the outbreak of COVID-19 infection. Cancer has been identified as one of the major comorbidities which cause more severe disease due to COVID-19 infection. Moreover, there are several resource limitations and restrictions to avail the standard oncological health facilities due to robust measures taken for infection control. In this situation, palliative care in cancer patients deserves special attention. Their symptom management, psychological, social, cultural needs tremendously increase during the epidemic. Thus, we need to recognize the unique palliative care needs of cancer patients during pandemic and formulate the plan to maintain continuity of services. Triaging systems are essential tools for proper resource allocation during a pandemic. Therefore, we suggest triaging tools for emergency in hospital palliative care services: community-based palliative care and end of life care for cancer patients. Incorporation of newer technologies and identifying the potential resources are the other key components of the preparedness strategy.

show abstract

“…Patients who are symptomatic and/or have an oncologic emergency and a more prolonged life expectancy are recommended to receive short course palliative RT, delay of RT or best supportive in the case of limited life expectancy is otherwise recommended. Thureau et al in their GEMO (the European Study Group of Bone Metastases) position paper, astutely note that the indications and treatment modalities for palliative bone metastases must be re-discussed in the context of COVID-19 [64][65][66][67]. Palliative treatments often require the most clinical judgement and can benefit the most from available evidence surrounding reduction in the number of treatments and the complexity thereof in a resource strained setting.…”

Section: Specific Considerationsmentioning

confidence: 99%

https://researchopenworld.com/management-of-cancer-patients-undergoing-radiation-therapy-during-the-novel-coronavirus-disease-2019-covid-19-pandemic-a-review-of-the-literature/#

2020

Cancer Stud Ther J

View full text Add to dashboard Cite

systemic management and may therefore not necessarily be immunecompromised, as well as the implication for daily attendance to a RT facility and the associated infection risk and how to best mitigate it. Other questions involve the ability to and safety of delaying or altering RT treatment schedules to minimize risk of infection. Important additional considerations abound in particular settings such a RT emergencies and treatment of the COVID-19 positive patient as well as the administration of radioactive isotopes such as radioactive iodine in thyroid patients who then need to self-isolate at home or as inpatients for several days. Since the COVID-19 pandemic has raised unprecedented challenges and questions, with ongoing lack of robust data, periodic review of the available evidence is important to help guide providers and patients in order to enable evidence-based care hence prompting this scoping review. Materials and Methods To carry out the scoping review, publications that specifically addressed the impact and management of cancer patients undergoing radiation therapy in the context of the COVID 19 pandemic were identified in PubMed using the following mesh terms: (("risk"[MeSH Terms] OR "risk"[All Fields]) OR "risk of "[All Fields]) AND ((((((("covid 19"[All Fields] OR "covid 2019"[All Fields]) OR "severe acute respiratory syndrome coronavirus 2"[Supplementary Concept]) OR "severe acute respiratory syndrome coronavirus 2"[All Fields]) OR "2019 ncov"[All Fields]) OR "sars cov 2"[All Fields]) OR "2019ncov"[All Fields]

show abstract

Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper

Cited by 23 publications

References 14 publications

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic

Palliative care delivery in cancer patients in the era of Covid-19 outbreak: Unique needs, barriers, and tools for solutions

https://researchopenworld.com/management-of-cancer-patients-undergoing-radiation-therapy-during-the-novel-coronavirus-disease-2019-covid-19-pandemic-a-review-of-the-literature/#

Contact Info

Product

Resources

About